HOOKIPA PHARMA INC's ticker is HOOK and the CUSIP is 43906K100. A total of 44 filers reported holding HOOKIPA PHARMA INC in Q3 2023. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $259,000 | -26.4% | 419,973 | +4.9% | 0.00% | – |
Q2 2023 | $352,000 | +13.2% | 400,405 | -5.3% | 0.00% | – |
Q1 2023 | $311,000 | -4.0% | 422,783 | +5.6% | 0.00% | – |
Q4 2022 | $324,000 | -16.9% | 400,309 | +37.6% | 0.00% | – |
Q3 2022 | $390,000 | -8.9% | 290,956 | +10.8% | 0.00% | – |
Q2 2022 | $428,000 | -26.7% | 262,693 | +2.7% | 0.00% | – |
Q1 2022 | $584,000 | +51.3% | 255,883 | +54.5% | 0.00% | – |
Q4 2021 | $386,000 | -38.3% | 165,651 | +55.7% | 0.00% | – |
Q3 2021 | $626,000 | +90.3% | 106,392 | +196.7% | 0.00% | – |
Q2 2021 | $329,000 | +104.3% | 35,858 | +200.3% | 0.00% | – |
Q1 2021 | $161,000 | -0.6% | 11,939 | -18.6% | 0.00% | – |
Q4 2020 | $162,000 | +84.1% | 14,668 | +57.3% | 0.00% | – |
Q3 2020 | $88,000 | -16.2% | 9,326 | +3.0% | 0.00% | – |
Q2 2020 | $105,000 | +54.4% | 9,051 | +9.7% | 0.00% | – |
Q1 2020 | $68,000 | +21.4% | 8,253 | +81.6% | 0.00% | – |
Q4 2019 | $56,000 | +100.0% | 4,544 | +22.7% | 0.00% | – |
Q3 2019 | $28,000 | +16.7% | 3,702 | +2.8% | 0.00% | – |
Q2 2019 | $24,000 | – | 3,600 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Redmile Group, LLC | 1,842,902 | $17,452,000 | 0.32% |
Samsara BioCapital, LLC | 116,602 | $1,104,000 | 0.31% |
Artal Group S.A. | 599,616 | $5,678,000 | 0.14% |
HHLR ADVISORS, LTD. | 943,254 | $8,933,000 | 0.07% |
DAFNA Capital Management LLC | 22,061 | $209,000 | 0.07% |
Baker Brothers Advisors | 700,481 | $6,634,000 | 0.03% |
ZACKS INVESTMENT MANAGEMENT | 72,064 | $682,000 | 0.01% |
HOWLAND CAPITAL MANAGEMENT LLC | 14,728 | $139,000 | 0.01% |
ETF MANAGERS GROUP, LLC | 14,374 | $139,000 | 0.00% |
Squarepoint Ops LLC | 12,699 | $120,000 | 0.00% |